National Academies Press: OpenBook

The Ebola Epidemic in West Africa: Proceedings of a Workshop (2016)

Chapter: Appendix A: References

« Previous: 4 Current and Future Research Opportunities
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

A

References

Amman, B. R., S. A. Carroll, Z. D. Reed, T. K. Sealy, S. Balinandi, R. Swanepoel, A. Kemp, B. R. Erickson, J. A. Comer, S. Campbell, D. L. Cannon, M. L. Khristova, P. Atimnedi, C. D. Paddock, R. J. Kent Crockett, T. D. Flietstra, K. L. Warfield, R. Unfer, E. Katongole-Mbidde, R. Downing, J. W. Tappero, S. R. Zaki, P. E. Rollin, T. G. Ksiazek, S. T. Nichol, J. S. Towner, and Y. Kawaoka. 2012. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog 8(10):e1002877.

Amman, B. R., M. E. Jones, T. K. Sealy, L. S. Uebelhoer, A. J. Schuh, B. H. Bird, J. D. Coleman-McCray, B. E. Martin, S. T. Nichol, and J. S. Towner. 2015. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 51(1):113-124.

Baize, S., D. Pannetier, L. Oestereich, T. Rieger, L. Koivogui, N. Magassouba, B. Soropogui, M. S. Sow, S. Keïta, H. De Clerck, A. Tiffany, G. Dominguez, M. Loua, A. Traoré, M. Kolié, E. R. Malano, E. Heleze, A. Bocquin, S. Mély, H. Raoul, V. Caro, D. Cadar, M. Gabriel, M. Pahlmann, D. Tappe, J. Schmidt-Chanasit, B. Impouma, A. K. Diallo, P. Formenty, M. Van Herp, and S. Günther. 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371(15):1418-1425.

Basler, C. F., X. Wang, E. Mühlberger, V. Volchkov, J. Paragas, H. D. Klenk, A. García-Sastre, and P. Palese. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97(22):12289-12294.

Bausch, D. G. 2015. The year that Ebola virus took over West Africa: Missed opportunities for prevention. Am J Trop Med Hygiene 92(2):229-232.

Bausch, D. G., and L. Schwarz. 2014. Outbreak of Ebola virus disease in Guinea: Where ecology meets economy. PLoS Negl Trop Dis 8(7):e3056.

Bornholdt, Z. A., T. Noda, D. M. Abelson, P. Halfmann, M. R. Wood, Y. Kawaoka, and E. O. Saphire. 2013. Structural rearrangement of Ebola virus VP40 begets multiple functions in the virus life cycle. Cell 154(4):763-774.

Bray, M., and S. Mahanty. 2003. Ebola hemorrhagic fever and septic shock. J Infect Dis 188(11): 1613-1617.

Canadian Critical Care Society, Canadian Association of Emergency Physicians, and Association of Medical Microbiology & Infectious Diseases Canada. 2014. Ebola clinical care guidelines: A guide for clinicians in Canada. Markham, ON: Canadian Critical Care Society.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

CDC (U.S. Centers for Disease Control and Prevention). 2014. Filoviridae. http://www.cdc.gov/vhf/virus-families/filoviridae.html (accessed November 3, 2016).

CDC. 2015. Interim guidance for U.S. Hospital preparedness for patients under investigation (PUIs) or with confirmed Ebola virus disease (EVD): A framework for a tiered approach. http://www.cdc.gov/vhf/ebola/hcp/us-hospital-preparedness.html (accessed June 9, 2015).

Cohen, J. 2014. Infectious disease. Ebola vaccines racing forward at record pace. Science 345(6202):1228-1229.

Cooper, D., K. J. Wright, P. C. Calderon, M. Guo, F. Nasar, J. E. Johnson, J. W. Coleman, M. Lee, C. Kotash, I. Yurgelonis, R. J. Natuk, R. M. Hendry, S. A. Udem, and D. K. Clarke. 2008. Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice. J Virol 82(1):207-219.

ECDC (European Centre for Disease Prevention and Control). 2015a. Communicable disease threats report, 25, 14-20 June 2015. Stockholm, Sweden: European Centre for Disease Prevention and Control.

ECDC. 2015b. ECDC updated risk assessment: Significant drop of Ebola cases in West Africa but control efforts still needed. http://ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1201 (accessed November 3, 2016).

Edelstein, M., P. Angelides, and D. L. Heymann. 2015. Ebola: The challenging road to recovery. Lancet 385(9984):2234-2235.

Fairley, J. K., P. E. Kozarsky, C. S. Kraft, J. Guarner, J. P. Steinberg, E. Anderson, J. T. Jacob, P. Meloy, D. Gillespie, T. R. Espinoza, A. Isakov, S. Vanairsdale, E. Baker, and H. M. Wu. 2016. Ebola or not? Evaluating the ill traveler from Ebola-affected countries in West Africa. Open Forum Infect Dis 3(1):ofw005.

Fasina, F. O., A. Shittu, D. Lazarus, O. Tomori, L. Simonsen, C. Viboud, and G. Chowell. 2014. Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014. Euro Surveill 19(40):20920.

Geisbert, T. W., and H. Feldmann. 2011. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis 204(Suppl 3):S1075-S1081.

Geisbert, T. W., A. C. Lee, M. Robbins, J. B. Geisbert, A. N. Honko, V. Sood, J. C. Johnson, S. de Jong, I. Tavakoli, A. Judge, L. E. Hensley, and I. Maclachlan. 2010. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet 375(9729):1896-1905.

Gire, S. K., A. Goba, K. G. Andersen, R. S. Sealfon, D. J. Park, L. Kanneh, S. Jalloh, M. Momoh, M. Fullah, G. Dudas, S. Wohl, L. M. Moses, N. L. Yozwiak, S. Winnicki, C. B. Matranga, C. M. Malboeuf, J. Qu, A. D. Gladden, S. F. Schaffner, X. Yang, P. P. Jiang, M. Nekoui, A. Colubri, M. R. Coomber, M. Fonnie, A. Moigboi, M. Gbakie, F. K. Kamara, V. Tucker, E. Konuwa, S. Saffa, J. Sellu, A. A. Jalloh, A. Kovoma, J. Koninga, I. Mustapha, K. Kargbo, M. Foday, M. Yillah, F. Kanneh, W. Robert, J. L. Massally, S. B. Chapman, J. Bochicchio, C. Murphy, C. Nusbaum, S. Young, B. W. Birren, D. S. Grant, J. S. Scheiffelin, E. S. Lander, C. Happi, S. M. Gevao, A. Gnirke, A. Rambaut, R. F. Garry, S. H. Khan, and P. C. Sabeti. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345(6202):1369-1372.

Gostin, L. O., and E. A. Friedman. 2014. Ebola: A crisis in global health leadership. Lancet 384(9951): 1323-1325.

Hashiguchi, T., M. L. Fusco, Z. A. Bornholdt, J. E. Lee, A. I. Flyak, R. Matsuoka, D. Kohda, Y. Yanagi, M. Hammel, J. E. Crowe, Jr., and E. O. Saphire. 2015. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160(5):904-912.

Hayman, D. T. 2015. Biannual birth pulses allow filoviruses to persist in bat populations. Proc Biol Sci 282(1803):20142591.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

Hayman, D. T., M. Yu, G. Crameri, L. F. Wang, R. Suu-Ire, J. L. Wood, and A. A. Cunningham. 2012. Ebola virus antibodies in fruit bats, Ghana, West Africa. Emerg Infect Dis 18(7):1207-1209.

IOM and NRC (Institute of Medicine and National Research Council). 2009. Sustaining global surveillance and response to emerging zoonotic diseases. Washington, DC: The National Academies Press.

Jahrling, P. B., J. B. Geisbert, J. R. Swearengen, T. Larsen, and T. W. Geisbert. 2007. Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates. J Infect Dis 196(Suppl 2):S400-S403.

Kortepeter, M. G., P. W. Smith, A. Hewlett, and T. J. Cieslak. 2015. Caring for patients with Ebola: A challenge in any care facility. Ann Intern Med 162(1):68-69.

Kugelman, J. R., M. S. Lee, C. A. Rossi, S. E. McCarthy, S. R. Radoshitzky, J. M. Dye, L. E. Hensley, A. Honko, J. H. Kuhn, P. B. Jahrling, T. K. Warren, C. A. Whitehouse, S. Bavari, and G. Palacios. 2012. Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection. PLoS ONE 7(11):e50316.

Kupferschmidt, K. 2014. Nigerian virologist delivers scathing analysis of Africa’s response to Ebola. Science Magazine.http://news.sciencemag.org/africa/2014/11/nigerian-virologist-delivers-scathing-analysis-africas-response-ebola (accessed November 3, 2016).

Leroy, E. M., B. Kumulungui, X. Pourrut, P. Rouquet, A. Hassanin, P. Yaba, A. Delicat, J. T. Paweska, J. P. Gonzalez, and R. Swanepoel. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438(7068):575-576.

Litterman, N., C. Lipinski, and S. Ekins. 2015. Small molecules with antiviral activity against the Ebola virus. F1000Res 4:38.

Maganga, G. D., J. Kapetshi, N. Berthet, B. Kebela Ilunga, F. Kabange, P. Mbala Kingebeni, V. Mondonge, J. J. Muyembe, E. Bertherat, S. Briand, J. Cabore, A. Epelboin, P. Formenty, G. Kobinger, L. Gonzalez-Angulo, I. Labouba, J. C. Manuguerra, J. M. Okwo-Bele, C. Dye, and E. M. Leroy. 2014. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 371(22):2083-2091.

Marí Saéz, A., S. Weiss, K. Nowak, V. Lapeyre, F. Zimmermann, A. Dux, H. S. Kuhl, M. Kaba, S. Regnaut, K. Merkel, A. Sachse, U. Thiesen, L. Villanyi, C. Boesch, P. W. Dabrowski, A. Radonic, A. Nitsche, S. A. Leendertz, S. Petterson, S. Becker, V. Krahling, E. Couacy-Hymann, C. Akoua-Koffi, N. Weber, L. Schaade, J. Fahr, M. Borchert, J. F. Gogarten, S. Calvignac-Spencer, and F. H. Leendertz. 2014. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med 7(1):17-23.

Meltzer, M. I., C. Y. Atkins, S. Santibanez, B. Knust, B. W. Petersen, E. D. Ervin, S. T. Nichol, I. K. Damon, and M. L. Washington. 2014. Estimating the future number of cases in the Ebola epidemic—Liberia and Sierra Leone, 2014-2015. MMWR Suppl 63(3):1-14.

Miranda, M. E., and N. L. Miranda. 2011. Reston ebolavirus in humans and animals in the Philippines: A review. J Infect Dis 204(Suppl 3):S757-S760.

Mire, C. E., J. B. Geisbert, K. N. Agans, B. A. Satterfield, K. M. Versteeg, E. A. Fritz, H. Feldmann, L. E. Hensley, and T. W. Geisbert. 2014. Durability of a vesicular stomatitis virus-based Marburg virus vaccine in nonhuman primates. PLoS ONE 9(4):e94355.

Mohan, G. S., W. Li, L. Ye, R. W. Compans, and C. Yang. 2012. Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog 8(12):e1003065.

MSF (Médecins Sans Frontières). 2015. Pushed to the limit and beyond: A year into the largest ever Ebola outbreaks. Geneva, Switzerland: MSF.

Mupapa, K., M. Massamba, K. Kibadi, K. Kuvula, A. Bwaka, M. Kipasa, R. Colebunders, and J. J. Muyembe-Tamfum. 1999. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 179(Suppl 1):S18-S23.

Muyembe-Tamfum, J. J., S. Mulangu, J. Masumu, J. M. Kayembe, A. Kemp, and J. T. Paweska. 2012. Ebola virus outbreaks in Africa: Past and present. Onderstepoort J Vet Res 79(2):451.

Nature. 2014. First response, revisited. Nature 513(7519):459.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

Olabode, A. S., X. Jiang, D. L. Robertson, and S. C. Lovell. 2015. Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak. Virology 482:202-207.

Onishi, N. 2015. Empty Ebola clinics in Liberia are seen as misstep in U.S. relief effort. New York Times. http://www.nytimes.com/2015/04/12/world/africa/idle-ebola-clinics-in-liberia-are-seenas-misstep-in-us-relief-effort.html?_r=0 (accessed November 3, 2016).

Osterholm, M. T., K. A. Moore, N. S. Kelley, L. M. Brosseau, G. Wong, F. A. Murphy, C. J. Peters, J. W. LeDuc, P. K. Russell, M. Van Herp, J. Kapetshi, J. J. Muyembe, B. K. Ilunga, J. E. Strong, A. Grolla, A. Wolz, B. Kargbo, D. K. Kargbo, D. A. Sanders, and G. P. Kobinger. 2015. Transmission of Ebola viruses: What we know and what we do not know. MBio 6(2):e00137.

Paweska, J. T., P. Jansen van Vuren, J. Masumu, P. A. Leman, A. A. Grobbelaar, M. Birkhead, S. Clift, R. Swanepoel, and A. Kemp. 2012. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with Vero cells-adapted Hogan strain of Marburg virus. PLoS ONE 7(9):e45479.

Presidential Commission for the Study of Bioethical Issues. 2015. Ethics and Ebola: Public health planning and response. Washington, DC: U.S. Department of Health and Human Services.

RKI (Robert Koch Institute). 2014. Framework Ebola virus disease: Intervention preparedness in Germany. Berlin, Germany: Robert Koch Institute.

Saphire, E. O. 2013. An update on the use of antibodies against the filoviruses. Immunotherapy 5(11):1221-1233.

Schoepp, R. J., C. A. Rossi, S. H. Khan, A. Goba, and J. N. Fair. 2014. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis 20(7):1176-1182.

Smith, P. W., A. O. Anderson, G. W. Christopher, T. J. Cieslak, G. J. Devreede, G. A. Fosdick, C. B. Greiner, J. M. Hauser, S. H. Hinrichs, K. D. Huebner, P. C. Iwen, D. R. Jourdan, M. G. Kortepeter, V. P. Landon, P. A. Lenaghan, R. E. Leopold, L. A. Marklund, J. W. Martin, S. J. Medcalf, R. J. Mussack, R. H. Neal, B. S. Ribner, J. Y. Richmond, C. Rogge, L. A. Daly, G. A. Roselle, M. E. Rupp, A. R. Sambol, J. E. Schaefer, J. Sibley, A. J. Streifel, S. G. Essen, and K. L. Warfield. 2006. Designing a biocontainment unit to care for patients with serious communicable diseases: A consensus statement. Biosecur Bioterror 4(4):351-365.

Srivastava, P. 2015. Update: Ebola virus disease epidemic—West Africa, February 2015. Atlanta, GA: U.S. Centers for Disease Control and Prevention.

Stanley, D. A., A. N. Honko, C. Asiedu, J. C. Trefry, A. W. Lau-Kilby, J. C. Johnson, L. Hensley, V. Ammendola, A. Abbate, F. Grazioli, K. E. Foulds, C. Cheng, L. Wang, M. M. Donaldson, S. Colloca, A. Folgori, M. Roederer, G. J. Nabel, J. Mascola, A. Nicosia, R. Cortese, R. A. Koup, and N. J. Sullivan. 2014. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med 20(10):1126-1129.

Sullivan, N. J., L. Hensley, C. Asiedu, T. W. Geisbert, D. Stanley, J. Johnson, A. Honko, G. Olinger, M. Bailey, J. B. Geisbert, K. A. Reimann, S. Bao, S. Rao, M. Roederer, P. B. Jahrling, R. A. Koup, and G. J. Nabel. 2011. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med 17(9):1128-1131.

Towner, J. S., B. R. Amman, T. K. Sealy, S. A. Carroll, J. A. Comer, A. Kemp, R. Swanepoel, C. D. Paddock, S. Balinandi, M. L. Khristova, P. B. Formenty, C. G. Albarino, D. M. Miller, Z. D. Reed, J. T. Kayiwa, J. N. Mills, D. L. Cannon, P. W. Greer, E. Byaruhanga, E. C. Farnon, P. Atimnedi, S. Okware, E. Katongole-Mbidde, R. Downing, J. W. Tappero, S. R. Zaki, T. G. Ksiazek, S. T. Nichol, and P. E. Rollin. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 5(7):e1000536.

Uyeki, T. M., B. R. Erickson, S. Brown, A. K. McElroy, D. Cannon, A. Gibbons, T. Sealy, M. H. Kainulainen, A. J. Schuh, C. S. Kraft, A. K. Mehta, G. M. Lyon, 3rd, J. B. Varkey, B. S. Ribner, R. T. Ellison, 3rd, E. Carmody, G. J. Nau, C. Spiropoulou, S. T. Nichol, and U. Stroher. 2016. Ebola virus persistence in semen of male survivors. Clin Infect Dis 62(12):1552-1555.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

Volchkova, V. A., O. Dolnik, M. J. Martinez, O. Reynard, and V. E. Volchkov. 2011. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 204(Suppl 3):S941-S946.

von Drehle, D., and A. Baker. 2014. The Ebola fighters: The ones who answered the call. Time magazine, December 10, 2014.

WHO (World Health Organization). 2015a. Current context and challenges; stopping the epidemic; and preparedness in non-affected countries and regions. Geneva, Switzerland: World Health Organization.

WHO. 2015b. Ebola situation report—10 June 2015. Geneva, Switzerland: World Health Organization.

WHO. 2015c. Ensuring WHO’s capacity to prepare for and respond to future large-scale and sustained outbreaks and emergencies. Geneva, Switzerland: World Health Organization.

WHO. 2015d. One year into the Ebola epidemic: A deadly, tenacious and unforgiving virus. Geneva, Switzerland: World Health Organization.

WHO. 2015e. Sexual transmission of the Ebola virus: Evidence and knowledge gaps. Geneva, Switzerland: World Health Organization.

WHO. 2016a. Ebola data and statistics: Situation summary. Geneva, Switzerland: World Health Organization.

WHO. 2016b. IHR procedures concerning public health emergencies of international concern (PHEIC). http://www.who.int/ihr/procedures/pheic/en (accessed August 11, 2016).

World Bank. 2014. The economic impact of the 2014 Ebola epidemic: Short and medium term estimates for West Africa. Washington, DC: The World Bank Group.

Wu, H. M., J. K. Fairley, J. Steinberg, and P. Kozarsky. 2015. The potential Ebola-infected patient in the ambulatory care setting: Preparing for the worst without compromising care. Ann Intern Med 162(1):66-67.

Xie, F. Y., M. C. Woodle, and P. Y. Lu. 2006. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov Today 11(1-2):67-73.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×

This page intentionally left blank.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 67
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 68
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 69
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 70
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 71
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2016. The Ebola Epidemic in West Africa: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23653.
×
Page 72
Next: Appendix B: Ebola: A View from the National Institute of Allergy and Infectious Diseases »
The Ebola Epidemic in West Africa: Proceedings of a Workshop Get This Book
×
Buy Paperback | $50.00 Buy Ebook | $39.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The most recent Ebola epidemic that began in late 2013 alerted the entire world to the gaps in infectious disease emergency preparedness and response. The regional outbreak that progressed to a significant public health emergency of international concern (PHEIC) in a matter of months killed 11,310 and infected more than 28,616. While this outbreak bears some unique distinctions to past outbreaks, many characteristics remain the same and contributed to tragic loss of human life and unnecessary expenditure of capital: insufficient knowledge of the disease, its reservoirs, and its transmission; delayed prevention efforts and treatment; poor control of the disease in hospital settings; and inadequate community and international responses.

Recognizing the opportunity to learn from the countless lessons of this epidemic, the National Academies of Sciences, Engineering, and Medicine convened a workshop in March 2015 to discuss the challenges to successful outbreak responses at the scientific, clinical, and global health levels. Workshop participants explored the epidemic from multiple perspectives, identified important questions about Ebola that remained unanswered, and sought to apply this understanding to the broad challenges posed by Ebola and other emerging pathogens, to prevent the international community from being taken by surprise once again in the face of these threats. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!